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Introduction {#sec001}
============

*Klebsiella* spp. are Gram-negative rod shaped bacteria that cause bacterial pneumonia with a high fatality rate if infection remains untreated in the clinical setting \[[@pone.0214326.ref001]\]. Globally, the vast majority of *Klebsiella* infections are hospital-acquired. Nosocomial *Klebsiella* infections are mainly caused by *Klebsiella pneumoniae*, the medically most important species of the genus which primarily attacks immune-compromised individuals who are hospitalized and suffer from severe underlying diseases such as diabetes mellitus, chronic pulmonary obstruction or even cancer. It is estimated that *Klebsiella* spp. cause 8% of all nosocomial bacterial infections in the United States and Europe, with 50.1% of these cases being caused by *Klebsiella pneumoniae* placing *Klebsiella* spp. among the eight most important infectious pathogens in hospitals \[[@pone.0214326.ref001]\]. In 1983, the first report of a plasmid-mediated extended spectrum beta-lactamases (*ESBLs*) capable of hydrolyzing extended-spectrum cephalosporins was discovered \[[@pone.0214326.ref002],[@pone.0214326.ref003]\]. Carbapenems are one of the last lines of antibiotic treatment for severe drug-resistant bacterial infections, and are now the treatment of choice for serious infections caused by pathogens carrying the *ESBL* gene. This has led to an increased reliance on carbapenems in clinical practice \[[@pone.0214326.ref004]\]. In tandem with this, the first carbapenemase producing *K*. *pneumoniae* isolate was reported in North Carolina in 2001. This enzyme was termed *K*. *pneumoniae* carbapenemase (KPC) and conferred resistance to carbapenem antibiotics \[[@pone.0214326.ref005]\]. KPCs are encoded by the gene *bla*KPC, whose potential for inter-species and geographic dissemination is largely explained by its location within a Tn3-type transposon, Tn4401 that is capable of inserting itself into diverse plasmids of Gram-negative bacteria. Although *K*. *pneumoniae* remains the most prevalent bacterial species carrying KPCs, the enzyme has been identified in several other Gram-negative bacilli such as *Escherichia coli*, *Pseudomonas aeruginosa* and *Salmonella enterica* due to horizontal gene transfer \[[@pone.0214326.ref006]\]. To worsen this issue, KPC-producing *K*. *pneumoniae* (KPC-KP) possesses innate antibiotic resistance in the form of an efflux pump, which generally removes the antibiotics that have penetrated the bacterial membrane, from the cytoplasm into the extracellular environment. Membrane permeability can also be altered in the presence of antibiotics; preventing the access of antibiotics into the cells, which when coupled to the other mechanisms, enables resistance against higher concentrations of antibiotics \[[@pone.0214326.ref007]\].

In order to address to this particular issue, there had been constant efforts to discover novel antimicrobials for clinical use. Natural products such as essential oil consisting a plethora of chemical compounds, are becoming a popular mainstream platform for researchers in drug discovery \[[@pone.0214326.ref008]\]. Numerous studies have also demonstrated the efficacy of essential oils from curry plant (*Helichrysum italicum* (Roth) G. Don fil.), peppermint (*Mentha* x *piperita* L.), tea tree (*Melaleuca alternifolia* (Maiden & Betche) Cheel.) and marjoram (*Origanum majorana* L.) as promising antimicrobials. Multiple studies have shown the synergistic effects between various essential oils and antibiotics, potentially solving the antibiotic resistance issue in the clinical setting \[[@pone.0214326.ref009]--[@pone.0214326.ref014]\]. Despite this, only a few studies have been carried out to elucidate the mode of action of several essential oils on different bacteria; most of these studies have postulated that essential oils exert their antimicrobial activities by disrupting bacterial cell membrane and/or their efflux systems through various assays \[[@pone.0214326.ref015]--[@pone.0214326.ref017]\]. For example, de Souza et al. (2009) postulated that *Origanum vulgare* L. essential oil affects the membrane permeability of *Staphylococcus aureus* by studying potassium ion efflux and scanning electron microscopy \[[@pone.0214326.ref015]\]. Similarly, Silva et al. (2011) hypothesized that coriander essential oil exerts its bactericidal activity towards both Gram-positive and Gram--negative bacteria via membrane damage by measuring their efflux activity, respiratory activity and membrane potential \[[@pone.0214326.ref016]\]. To further support and understand the antimicrobial activity of essential oils, mass spectrometry-based proteomics analysis has become the tool of choice offering the identification and quantification of the proteome of an organism. There has been a tremendous improvement in instrument performance and the computational tools used in proteomic studies in recent years, which facilitates the understanding of the mechanisms of action of potential antimicrobial agents in the clinical setting. In the most widely used "bottom-up" approach to proteomics, liquid chromatography coupled with mass spectrometry (LC-MS/MS), enables a complex mixture of proteins to be first subjected to enzymatic cleavage; the resulting peptide products are separated based on chemical or physical properties and analyzed using a mass spectrometer. The proteome can then be analyzed, quantified and compared by using third party analytical software such as Progenesis QI (Progenesis Group Sdn. Bhd.) or Perseus (Max Planck Institute of Biochemistry). For instance, Xu et al. (2015) identified the mode of action of paclitaxel as chemotherapeutic drugs in HeLa cells by tampering with the abundance of tumor suppressor PDCD4 via LC-MS/MS proteomic profiling \[[@pone.0214326.ref018]\]. Similarly, Kawatani et al. (2016) also revealed the role of collismycin A as an iron chelator antagonizing cancer cells, using a proteomic approach \[[@pone.0214326.ref019]\].

In our previous study, we have successfully shown that cinnamon bark (*Cinnamomon verum* J. Presl) essential oil (CBO) is, in fact, an effective antimicrobial when used against KPC-KP with an extremely low minimum inhibitory concentration (MIC) of 0.16% (v/v) \[[@pone.0214326.ref011]\]. Furthermore, combinations of CBO and antibiotic meropenem further reduced the MIC of CBO to 0.08% (v/v) which makes it a putative candidate to be used as an antimicrobial in the clinical setting \[[@pone.0214326.ref011]\]. Other studies showed that CBO with a low MIC value is effective against a variety of Gram-positive and Gram--negative pathogens. Zamirah and colleagues (2013) demonstrated that CBO is effective against oral pathogens such as *Aggregatibacter actinomycetemcomitans*, *Fusobacterium nucleatum*, [*Porphyromonas gingivalis*](https://en.wikipedia.org/wiki/Porphyromonas_gingivalis), [*Streptococcus salivarius*](https://en.wikipedia.org/wiki/Streptococcus_salivarius), *S*. *mitis* and *S*. *mutans* with a low MIC ranging from 0.02 to 0.06% (v/v) \[[@pone.0214326.ref020]\]. Kaskatepe et al (2016) also showed that CBO is highly effective against other opportunistic pathogens, including *Escherichia coli*, *Pseudomonas aeruginosa* and multidrug-resistant *Staphylococcus aureus* (MRSA), with a MIC ranging from 0.009% to 0.078% (v/v) \[[@pone.0214326.ref021]\]. As already mentioned above, preliminary studies had postulated that essential oils affect bacterial membrane and/or their efflux system via numerous assays. Nevertheless, none had explained or gave an overview on the overall changes that the bacterial cells undergo when exposed to essential oils, especially in the perspective of proteomics. Thus, this study was carried out to understand and possibly bridge the missing links among previous studies regarding the mode of action of essential oils as an antimicrobial agent from the proteomic perspective, using CBO and KPC-KP as a model of study.

Materials and methods {#sec002}
=====================

CBO and KPC-producing *K*. *pneumoniae* {#sec003}
---------------------------------------

CBO (Cinnamon bark Sri Lanka, lot number: 6488) used throughout the study was purchased from Aroma Trading Ltd. (Milton Keynes, UK). The composition of CBO had been determined in our previous study via GC-MS \[[@pone.0214326.ref010]\]. The CBO was filter-sterilized using a 0.22 μm PES syringe membrane filter (Bioflow, Malaysia). KPC-producing *K*. *pneumoniae*, *K*. *pneumoniae* BAA-1705 (KPC-KP) was purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) and was cultured on Mueller-Hinton broth (MHB) and agar (MHA) both from Sigma Aldrich, USA.

CBO treatment and protein extraction {#sec004}
------------------------------------

KPC-KP cell cultures were divided into two treatment groups, namely control (no treatment) and CBO treated prior to protein extraction. The CBO final concentration used was 0.08% (v/v), as determined by Yang et al. (2017) \[[@pone.0214326.ref011]\]. Both treatment groups had a final volume of 50 mL, supplemented with Tween 80 at final concentration of 10% to enhance the solubility of CBO and a standard inoculum of 1 × 10^5^ cfu/mL KPC-KP cells. Samples were incubated at 37°C with shaking at 200 rpm for 16 h to obtain sufficient cells for protein extraction. The cells from both treatment groups were pelleted by centrifugation at 9000 rpm for 10 min, washed for at least three times and resuspended in 500 μL cold protein extraction buffer (50 mM ammonium bicarbonate, 10 mM phenylmethylsulfonyl fluoride). Samples were then sonicated on ice at 20 amplitude for 10 cycles to lyse the cells; each cycle consisted of 10 seconds of sonication followed by 20 s of cooling, with a Qsonica Sonicator Q55 (Fischer Scientific, USA). Sonicated samples were then pelleted at 4°C and 10000 rpm for 1 h; supernatants were then collected and quantified via Bradford assay. The protein concentration of each sample was standardized to 1 mg/mL for the subsequent proteomic analysis. Treatment and analysis was standardized in three distinct biological replicates to ensure reproducibility of the experiment.

Peptide digestion {#sec005}
-----------------

Approximately 100 μg of total protein was resuspended in 100 μL of 50mM ammonium bicarbonate (pH 8.0). RapiGest (Waters Corporation, USA) at final concentration of 0.05% was added to the protein in equal parts. Protein from each sample was then concentrated to 100μL using Vivaspin column (GE Healthcare, USA) with a molecular weight cut-off (MWCO) of 3000 and incubated at 80°C for 15 min. The proteins were reduced in the presence of 5 mM dithiothreitol (DTT) at 60°C for 30 min, and then alkylated in the dark using 10 mM iodoacetamide at room temperature for 45 min. Proteolytic digestion was performed using Trypsin Gold (Promega, USA) at a ratio of 1:200 parts of protein, followed by incubation at 37°C overnight. Tryptic digestion and RapiGest activity were terminated by the addition of 1 μL concentrated trifluoroacetic acid (TFA) followed by the incubation of samples at 37°C for 20 min. The tryptic peptide solution of each sample was centrifuged at 14000 rpm for 20 min, and the resulting supernatants were collected in clean microcentrifuges tube kept at -80°C until subsequent analysis.

Peptide separation and MS analysis {#sec006}
----------------------------------

The nanoLC-MS/MS analysis was performed on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, USA). The samples (2 μL containing 2 μg peptides) were injected and separated on an EASY-nLC 1000 (Dionex, Thermo Scientific, USA) equipped with an Easy-Spray Column Acclaim PepMap C18 100Å (2 μm, 50 μm × 15 cm, Thermo Scientific, USA). Samples were separated at a flow rate of 250 nL/min and using a gradient of 5% to 50% acetonitrile (ACN) in 0.1% formic acid (FA) for 45 min followed by a further gradient to 85% ACN in 0.1% FA for 2 min. The column was equilibrated back to 5% ACN with 0.1% FA over 1 min and maintained at 5% CAN until the next sample injection. Mass spectrometry was conducted in a positive ion mode with a nanospray voltage of 1.5 kV and a source temperature of 250°C. The instrument was operated in a data-dependent acquisition (DDA) mode with an Orbitrap MS (OTMS) survey scan using the following parameters: mass range of m/z 310--1800 with resolving power of 120000, automatic gain control (AGC) of 400000 and a maximum injection time of 50 ms. The Top Speed Mode of 3 seconds was used in the selection of precursors with the monoisotopic charge state of 2 to 7. These precursors were further analysed by MS/MS scanning. All precursors were filtered using a 20 s dynamic exclusion window and intensity threshold of 5000. The MS/MS spectra were analysed using ion trap MS (ITMS) with the following parameters: rapid scan rate with resolving power of 60000, AGC of 100, isolation window of 1.6 m/z and maximum injection time of 250 ms. Precursors were then fragmented by collision-induced dissociation (CID) and high-energy collision dissociation (HCD) at normalized collision energy of 30% to 28%.

Protein identification {#sec007}
----------------------

Raw data were processed using Thermo Scientific Proteome Discoverer Software v2.1 with the SEQUEST HT search engine. The MS ion intensities were calculated based on the accurate mass and time tag strategy. The accurate alignment of the detected LC retention time and *m/z* value across different analyses, together with the area under chromatographic elution profiles of the identified peptides could be compared between different samples. For protein identification, data was searched against the Uniprot *K*. *pneumoniae* database with 1% strict FDR and 5% relaxed FDR criteria using Percolator. Search parameters were set to 2 miscleavages with fixed modification of carbamidomethylation and variable modification through methionine oxidation or asparagine and glutamine deamidation. A fragment tolerance of 0.6 Da and a precursor tolerance of 10 ppm were used with trypsin as a digestion enzyme. Proteins with at least 2 unique peptides implied a greater confidence of protein identity.

Protein quantification and data analysis {#sec008}
----------------------------------------

Protein quantification and statistical analyses were performed using Perseus Software v1.6.0.7 (Max Planck Institute of Biochemistry). Each control and treated samples analysis consisted of three biological replicates with three technical replicates, independently injected into the LCMS/MS. The protein file with three technical replicates in txt. format from Proteome Discoverer software were uploaded to Perseus for further comparative analysis between the samples. The data were log2-transformed to stabilise the variance and scale-normalised to the same mean intensity across the technical replicates. The mean values for all three technical replicates of the same biological samples were grouped together in the same matrix and valid values were obtained by filtering with 'at least 2', eliminating proteins which only existed in one of the technical replicates. Finally, all biological replicates of the same treatment group were consolidated into the same matrix, with the missing values imputated with the random number derived from a normal distribution. The histograms were plotted to compare the ratio distributions between all samples. Differentially expressed proteins between control and treatment were detected using a T-test, the *p*-values were also adjusted for multiple-testing using the permutation-based false discovery rate, with a number of randomization of 250. Proteins were considered to be significantly differentially expressed between treatment groups with adjusted *p*-values of \<0.05 and a fold changes of ≤ -1 or ≥ +1.

CBO treatment, RNA extraction and cDNA synthesis {#sec009}
------------------------------------------------

KPC-KP cell culture were treated with CBO or vehicle buffer prior to RNA extraction. The CBO final concentration used was 0.08% (v/v), as determined in our previous work \[[@pone.0214326.ref011]\]. Both treatment groups had a final volume of 50 mL, and contained Tween 80 at final concentration of 10% to enhance the solubility of CBO. The standard KPC-KP cell inoculum was 1 × 10^5^ cfu/mL. Samples were incubated at 37°C with shaking at 200 rpm for 4 h followed by RNA extraction using the TransZol RNA purification kit (Transgen Biotech, China). RNA (0.5 ng) was subjected to reverse transcription with QuantiNova Reverse Transcription Kit (QIAGEN, Germany) in a 20-μl reaction volume. The synthesized complementary DNA (cDNA) was stored at −20 °C until further use.

Proteomic expression validation through qRT-PCR analysis {#sec010}
--------------------------------------------------------

The RNA abundance for several upregulated proteins from CBO-treated *K*. *pneumoniae* BAA-1705 was determined by qRT-PCR using QuantiNova SYBR Green PCR (QIAGEN, Germany) on CFX96 Touch Real-Time PCR Detection System (Bio-Rad Laboratories, Inc, USA). The Livak method was employed to assess the relative expression of three upregulated genes, namely cytidine deaminase (*cdd*), thiamine phosphate synthase (*thiE*) and uridine phosphorylase (*udp*), one down regulated gene, namely, 3-hydroxydecanoyl-\[acyl-carrier-protein\] dehydratase (*fabA*) and two housekeeping genes, namely *16S rRNA* and *OmpK36* porin. Reactions were performed in triplicate and data were analysed by using the CFX Manage Software (Bio-Rad). The thermal cycling conditions were as follows: 95 °C for 2 min, followed by 40 cycles of 95 °C for 5 s, and 60 °C for 10 s. In all experiments, no template reactions were used as negative controls.

Results and discussion {#sec011}
======================

Comparative proteome profiling of KPC-KP treated with CBO {#sec012}
---------------------------------------------------------

Comparative proteomic analysis was carried out between non-treated and CBO-treated KPC-KP cells in four independent experiments using Perseus Software v1.6.0.7 (Max Planck Institute of Biochemistry). The protein profiles of treated and non-treated cells varied significantly with no outliers from the replicates, as shown in the principle component analysis (PCA) in [Fig 1A](#pone.0214326.g001){ref-type="fig"}. In addition, the Pearson correlation values between non-treated and CBO-treated KPC-KP were of high confidence (0.788 to 0.822), indicating that both the compared groups are of the same organism with no contamination within the samples ([Fig 1B](#pone.0214326.g001){ref-type="fig"}). The volcano plot ([Fig 1C](#pone.0214326.g001){ref-type="fig"}) of the comparative proteome between non-treated and CBO-treated KPC-KP cells showed a total of 46 proteins with significantly different abundance; 25 proteins of which were upregulated, whereas the other 21 proteins were downregulated in response to CBO treatment.

![Exploratory analysis output of non-treated and CBO-treated KPC-KP cells using Perseus v1.6.0.7 software.\
(A) Principal component analysis (PCA) identifies differences between the non-treated (designated with green square) and CBO-treated (designated with red square) KPC-KP cells. (B) Multi-scatter plot with the Pearson correlation value of one of the profiles from the non-treated and CBO-treated KPC-KP cells. (C) Volcano plot showing up- (designated with green square) and downregulated (designated with red square) proteins from the CBO-treated KPC-KP cells.](pone.0214326.g001){#pone.0214326.g001}

A total of 384 proteins were identified from the non-treated cells, whereas only 242 proteins were identified from the CBO-treated cells, A total of 152 proteins were only expressed in the non-treated cells while 10 proteins were only expressed in the CBO-treated cells, the other 232 proteins were present in both groups of cells ([Fig 2A](#pone.0214326.g002){ref-type="fig"}). Proteins that were present in both samples were compared within the Perseus software to measure up- and downregulation of proteins while the rest of the proteins are referred as absent or present from each treatment group ([Table 1](#pone.0214326.t001){ref-type="table"}). Proteins that were differentially present or absent, and up- or downregulated between the two groups of cells were subjected to gene ontology analysis with regards to biological process involvement, cellular component and molecular function ([Fig 2](#pone.0214326.g002){ref-type="fig"}). The majority of the proteins identified were linked to cellular and metabolic processes (37.5% and 35.7%), a number were also involved with cellular component organization and response to stimulus (8.2% and 7.9%) ([Fig 2B](#pone.0214326.g002){ref-type="fig"}). Cellular component wise, the majority of the proteins identified were categorized under cytosol and cytoplasm (41.5% and 30.3%) followed by macromolecular complex and plasma membrane (11.9% and 10.5%; [Fig 2d](#pone.0214326.g002){ref-type="fig"}). The categorization by molecular function identified proteins that were involved in catalytic activity and binding (46% and 45%) in addition to proteins that were structural molecules and or had transcription regulator activity (2.8% and 2.1%) ([Fig 2F](#pone.0214326.g002){ref-type="fig"}). Most proteins involved in biological processes, cellular component and molecular function were downregulated ([Fig 2C, 2E and 2G](#pone.0214326.g002){ref-type="fig"}).

![Comparative proteomic analysis of protein from CBO-treated KPC-KP cells.\
(A) Venn diagram of the total protein obtained from non-treated KPC-KP and CBO-treated KPC-KP cells, a total of 394 proteins were identified in non-treated KPC-KPs (384 proteins) and CBO-treated KPC-KPs (242 proteins) together. These total proteins were categorized based on the related biological process (B), cellular component (D) and molecular function (F). The numbers of upregulated and downregulated genes were also compared with respect to the relevant biological process (C), cellular component (E) and molecular function (G). Gene ontology analysis in terms of biological process of protein with significant abundance from CBO-treated KPC-KP cells.](pone.0214326.g002){#pone.0214326.g002}

10.1371/journal.pone.0214326.t001

###### Top 100 proteins showing significant abundance difference (together with their accession numbers) in KPC-KP cells treated with CBO.

The list is sorted according to descending positive or negative fold changes of each protein.

![](pone.0214326.t001){#pone.0214326.t001g}

  No                                      Proteins                                                           Gene Name   Uniprot Accession No.   General Function                   Fold Change
  --------------------------------------- ------------------------------------------------------------------ ----------- ----------------------- ---------------------------------- -------------
  Upregulated Proteins                                                                                                                                                              
  1                                       Autonomous glycyl radical cofactor                                 grcA        A6TCJ1                  Stress response                    7.07
  2                                       Beta-galactosidase 2                                               lacZ2       A6TI29                  Carbohydrate metabolism            4.65
  3                                       50S ribosomal protein L33                                          rpmG        B5XTG7                  Protein biosynthesis               3.97
  4                                       Sucrose porin                                                      scrY        P27218                  Transport                          3.05
  5                                       ATP-dependent protease ATPase subunit HslU                         hslU        B5XZ37                  Stress response                    2.68
  6                                       Uridine phosphorylase                                              udp         P52671                  Pyrimidine biosynthesis            2.57
  7                                       Agmatinase                                                         speB        B5XUB2                  Amine and polyamine biosynthesis   2.55
  8                                       Phosphoribosylaminoimidazole-succinocarboxamide synthase           purC        A6TC99                  Purine biosynthesis                2.52
  9                                       Phosphomethylpyrimidine synthase                                   thiC        A6TGQ1                  Thiamine biosynthesis              2.33
  10                                      Phosphoribosylformylglycinamidine cyclo-ligase                     purM        A6TCB3                  Purine biosynthesis                2.21
  11                                      NAD-dependent malic enzyme                                         maeA        A6T9K7                  Carbohydrate metabolism            2.19
  12                                      Probable Fe(2+)-trafficking protein                                yggX        A6TDX0                  Stress response                    2.17
  13                                      Thiamine-phosphate synthase                                        thiE        A6TGQ0                  Thiamine biosynthesis              2.08
  14                                      Chaperone protein DnaK                                             dnaK        A6T4F4                  Stress response                    1.73
  15                                      Iron-sulfur cluster insertion protein ErpA                         erpA        A6T4W0                  Stress response                    1.70
  16                                      Cytidine deaminase                                                 cdd         A6TBN1                  Purine biosynthesis                1.62
  17                                      Elongation factor Ts                                               tsf         A6T4X2                  Protein biosynthesis               1.58
  18                                      Ribosomal protein S12 methylthiotransferase RimO                   rimO        A6T6T1                  RNA processing and modification    1.50
  19                                      Dual-specificity RNA methyltransferase RlmN                        rlmN        A6TCD6                  RNA processing and modification    1.26
  20                                      Ribosomal RNA small subunit methyltransferase C                    rsmC        A6THY6                  RNA processing and modification    1.16
  CBO-treated KPC-KP Exclusive Proteins                                                                                                                                             
  21                                      Bifunctional protein GlmU                                          glmU        B5XZM7                  Peptidoglycan biosynthesis         CBO-treated
  22                                      Carbon storage regulator homolog                                   csrA        B5XVB9                  Protein biosynthesis               CBO-treated
  23                                      Cobalamin biosynthesis protein CobD                                cobD        A6TDC6                  Cobalamin biosynthesis             CBO-treated
  24                                      DNA ligase                                                         ligA        A6TC47                  Stress response                    CBO-treated
  25                                      Ferrochelatase                                                     hemH        B5Y0N2                  Porphyrin biosynthesis             CBO-treated
  26                                      Hydroxyacylglutathione hydrolase                                   gloB        A6T510                  Secondary metabolite metabolism    CBO-treated
  27                                      Integration host factor subunit beta                               ihfB        A6T704                  DNA processing                     CBO-treated
  28                                      Probable malate:quinone oxidoreductase (Fragment)                  mqo         O32719                  Energy synthesis                   CBO-treated
  29                                      tRNA 2-thiocytidine biosynthesis protein TtcA                      ttcA        B5XRN3                  RNA processing and modification    CBO-treated
  Downregulated Proteins                                                                                                                                                            
  30                                      3-hydroxydecanoyl-\[acyl-carrier-protein\] dehydratase             fabA        A6T748                  Fatty acid biosynthesis            -3.46
  31                                      ATP-dependent protease subunit HslV                                hslV        B5XZ36                  Stress response                    -3.25
  32                                      HTH-type transcriptional regulator IscR                            iscR        A6TCF2                  Stress response                    -3.05
  33                                      Ribosome maturation factor RimP                                    rimP        A6TEI9                  Ribosome biogenesis                -2.80
  34                                      50S ribosomal protein L32                                          rpmF        A6T7E9                  Translation                        -2.78
  35                                      Recombination-associated protein RdgC                              rdgC        B5Y109                  DNA processing                     -2.48
  36                                      Peptide methionine sulfoxide reductase MsrB                        msrB        A6T7R0                  Stress response                    -2.27
  37                                      6-phosphogluconate dehydrogenase, decarboxylating                  gnd         P41576                  Carbohydrate metabolism            -2.24
  38                                      50S ribosomal protein L17                                          rplQ        A6TEU7                  Protein biosynthesis               -2.13
  39                                      Cysteine desulfurase IscS                                          iscS        A6TCF1                  Stress response                    -1.95
  40                                      50S ribosomal protein L5                                           rplE        A6TEW0                  Protein biosynthesis               -1.94
  41                                      Uridine kinase                                                     udk         A6TBG6                  Pyrimidine biosynthesis            -1.89
  42                                      Probable septum site-determining protein MinC                      minC        A6TAX3                  Cell division                      -1.67
  43                                      UDP-4-amino-4-deoxy-L-arabinose---oxoglutarate aminotransferase    arnB        A6TFA0                  Lipopolysaccharide biosynthesis    -1.62
  44                                      S-adenosylmethionine synthase                                      metK        A6TDV1                  Protein biosynthesis               -1.58
  45                                      Glutamate---tRNA ligase                                            gltX        A6TC43                  Protein biosynthesis               -1.49
  46                                      Arginine---tRNA ligase                                             argS        A6TB43                  Protein biosynthesis               -1.39
  47                                      HTH-type transcriptional regulator MalT                            malT        A6TF41                  Carbohydrate metabolism            -1.28
  48                                      Protein TolB                                                       tolB        B5XZC1                  Cell division                      -1.10
  49                                      Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha   accA        A6T4Y7                  Lipid metabolism                   -1.08
  50                                      30S ribosomal protein S3                                           rpsC        B5XNA0                  Protein biosynthesis               -1.04
  Control KPC-KP Exclusive Proteins                                                                                                                                                 
  51                                      10 kDa chaperonin                                                  grosA       B5Y369                  Stress response                    Control
  52                                      1-deoxy-D-xylulose-5-phosphate synthase                            dxs         A6T5F3                  Thiamine biosynthesis              Control
  53                                      3-dehydroquinate synthase                                          aroB        A6TF13                  Chorismate biosynthesis            Control
  54                                      3-methyl-2-oxobutanoate hydroxymethyltransferase                   panB        A6T4T0                  Pantothenate biosynthesis          Control
  55                                      3-octaprenyl-4-hydroxybenzoate carboxy-lyase                       ubiD        A6TGM1                  Ubiquinone biosynthesis            Control
  56                                      3-phosphoshikimate 1-carboxyvinyltransferase                       aroA        B5XY87                  Chorismate biosynthesis            Control
  57                                      4-hydroxy-3-methylbut-2-enyl diphosphate reductase                 ispH        A6T4G3                  Isoprenoid biosynthesis            Control
  58                                      50S ribosomal protein L34                                          rpmH        A6TG05                  Protein biosynthesis               Control
  59                                      6-phosphogluconolactonase                                          pgl         A6T6J6                  Carbohydrate metabolism            Control
  60                                      Adenine phosphoribosyltransferase                                  apt         A6T5N2                  Purine metabolism                  Control
  61                                      Aminomethyltransferase                                             gcvT        A6TDR7                  Protein biosynthesis               Control
  62                                      Argininosuccinate synthase                                         argG        A6TEJ0                  Protein biosynthesis               Control
  63                                      ATP synthase epsilon chain                                         atpC        A6TG35                  Energy synthesis                   Control
  64                                      ATP-dependent RNA helicase RhlB                                    rhlB        A6TGG9                  RNA processing and modification    Control
  65                                      Biosynthetic arginine decarboxylase                                speA        B5XUB1                  Amine and polyamine biosynthesis   Control
  66                                      Catalase-peroxidase                                                katG        A6T9H9                  Stress response                    Control
  67                                      Cell division protein ZipA                                         zipA        A6TC48                  Cell division                      Control
  68                                      Cell division topological specificity factor                       minE        A6TAX5                  Cell division                      Control
  69                                      Chorismate synthase                                                aroC        A6TC15                  Chorismate biosynthesis            Control
  70                                      Chromosomal replication initiator protein DnaA                     dnaA        B5XT51                  DNA processing                     Control
  71                                      D-amino acid dehydrogenase                                         dadA        A6TAW4                  Protein biosynthesis               Control
  72                                      Dihydroorotase                                                     pyrC        A6T7D6                  Pyrimidine biosynthesis            Control
  73                                      Dihydroorotate dehydrogenase (quinone)                             pyrD        A6T739                  Pyrimidine biosynthesis            Control
  74                                      Dihydroxy-acid dehydratase                                         ilvD        A6TGF8                  Protein biosynthesis               Control
  75                                      DNA gyrase inhibitor YacG                                          yacG        A6T4P3                  DNA processing                     Control
  76                                      DNA mismatch repair protein MutS                                   mutS        A6TD24                  Stress response                    Control
  77                                      DnaA initiator-associating protein DiaA                            diaA        A6TEG8                  DNA processing                     Control
  78                                      Electron transport complex subunit C                               rnfC        B5XWP9                  Energy synthesis                   Control
  79                                      Elongation factor P---(R)-beta-lysine ligase                       epmA        A6TH74                  Protein biosynthesis               Control
  80                                      Endonuclease V                                                     nfi         A6TGQ5                  Stress response                    Control
  81                                      Exodeoxyribonuclease 7 small subunit                               xseB        B5Y0W9                  DNA processing                     Control
  82                                      Formate-dependent phosphoribosylglycinamide formyltransferase      purT        B5XQ21                  Purine metabolism                  Control
  83                                      Fructose-6-phosphate aldolase                                      fsa         A6TGD7                  Carbohydrate metabolism            Control
  84                                      Gamma-glutamyl phosphate reductase                                 proA        A6T561                  Protein biosynthesis               Control
  85                                      Glucans biosynthesis protein D                                     mdoD        B5XWS2                  Glycan metabolism                  Control
  86                                      Glucokinase                                                        glk         A6TC33                  Energy synthesis                   Control
  87                                      Glucosamine-6-phosphate deaminase                                  nagB        A6T6C1                  Carbohydrate metabolism            Control
  88                                      Glutamate 5-kinase                                                 proB        A6T562                  Protein biosynthesis               Control
  89                                      Glycerol-3-phosphate acyltransferase                               plsB        A6TGV0                  Phospholipid biosynthesis          Control
  90                                      Histidine biosynthesis bifunctional protein HisB                   hisB        A6TBC5                  Protein biosynthesis               Control
  91                                      Holliday junction ATP-dependent DNA helicase RuvA                  ruvA        B5XQ04                  Stress response                    Control
  92                                      HTH-type transcriptional regulator CysB                            cysB        P45600                  Protein biosynthesis               Control
  93                                      HTH-type transcriptional repressor PurR                            purR        A6TA06                  Purine metabolism                  Control
  94                                      Hydroxyethylthiazole kinase                                        thiM        A6TBJ8                  Thiamine biosynthesis              Control
  95                                      Imidazole glycerol phosphate synthase subunit HisF                 hisF        A6TBC8                  Protein biosynthesis               Control
  96                                      Iron-binding protein IscA                                          iscA        A6TCE9                  Stress response                    Control
  97                                      Ketol-acid reductoisomerase (NADP(+))                              ilvC        A6TGG1                  Protein biosynthesis               Control
  98                                      Large-conductance mechanosensitive channel                         mscL        B5XNC0                  Transport                          Control
  99                                      L-lactate dehydrogenase                                            lldD        A6TFK0                  Energy synthesis                   Control
  100                                     L-threonine 3-dehydrogenase                                        tdh         A6TFL2                  Protein biosynthesis               Control

Of the overlapping 232 proteins identified in both treatment groups, only 41 proteins showed significant differences, in terms of fold change between the groups. The majority of the proteins which showed significant abundance difference were downregulated (51.2%) when compared to the non-treated KPC-KP cells, whereas the other 48.8% of the proteins were upregulated as shown in [Table 1](#pone.0214326.t001){ref-type="table"}. Proteins that were absent or present in each treatment group were also listed in [Table 1](#pone.0214326.t001){ref-type="table"}, with proteins that were only present in the CBO-treated KPC-KP cells listed under the upregulated proteins whereas proteins which were only present in the non-treated KPC-KP cells listed under the downregulated protein section. These proteins were then subjected to KEGG pathway analysis to elucidate mechanism involved in the action of CBO on KPC-KP cells.

Bacterial membrane disruption {#sec013}
-----------------------------

The Gram negative bacterial cell outer barrier consists of three separate component, the outer membrane, the peptidoglycan and the plasma membrane \[[@pone.0214326.ref022]\]. Both the outer membrane and the plasma membrane are made up of a phospholipid bilayer embedded with membrane proteins. The biochemical feature which differentiates the layers is the presence of lipopolysaccharides uniquely in the outer membrane. Of the identified proteins from the KPC-KP cells, 10.5% were located at the bacterial membrane ([Fig 2D and 2E](#pone.0214326.g002){ref-type="fig"}). Following exposure to CBO, our proteomic profiling showed 5 outer membrane exclusive proteins and 26 plasma membrane exclusive proteins were completely lost after the exposure to CBO ([Table 2](#pone.0214326.t002){ref-type="table"}). Similarly, Wu and colleagues (2016) found that 3-*p*-trans-coumaroyl-2-hydroxyquinic acid, a phenolic compound isolated from Himalayan cedar essential oil caused bacterial membrane damage and the loss of membrane proteins due to specific interactions between the compound and the lipid and proteins within the bacterial membrane \[[@pone.0214326.ref023]\]. This disrupted the membrane integrity of the bacteria which caused the loss of plasma membrane protein. The downregulation of outer membrane integrity regulators such as the TolB porin-interacting protein, the large-conductance mechanosensitive channel and outer membrane protein assembly factor BamA in KPC-KP cells exposed to CBO also indicated the loss of membrane integrity in KPC-KP cells \[[@pone.0214326.ref024]\]. In addition, proteins involved in energy generation, such as the ATP synthase, the electron transport complex and the NADH-quinone oxidoreductases which are often embedded within the bacterial membrane were lost completely. This is yet another indicator for disrupted bacterial membrane integrity that may contribute to bacterial cell killing through the shutdown ofenergy production in CBO-treated KPC-KP cells. With compromised plasma membrane integrity, intracellular proteins easily escape into the extracellular environment as suggested by Ukuku et al. (2007) \[[@pone.0214326.ref025]\].

10.1371/journal.pone.0214326.t002

###### List of proteins belonging to the outer membrane and plasma membrane of KPC-KP cells and their relative status in proteomic profiling.

![](pone.0214326.t002){#pone.0214326.t002g}

  Uniprot Accession No.     Protein                                                                                                                Status
  ------------------------- ---------------------------------------------------------------------------------------------------------------------- --------------------------------------------------
  Outer membrane protein                                                                                                                           
  A6TGU6                    Maltoporin 2                                                                                                           Lost
  P40786                    Nucleoside-specific channel-forming protein tsx                                                                        Lost
  P24017                    Outer membrane protein A                                                                                               Upregulated by 2.04 folds
  A6T4X9                    Outer membrane protein assembly factor BamA                                                                            Lost
  A6T7G4                    Penicillin-binding protein activator LpoB                                                                              Lost
  P27218                    Sucrose porin                                                                                                          Lost
  Plasma membrane protein                                                                                                                          
  A6TGM1                    3-octaprenyl-4-hydroxybenzoate carboxy-lyase                                                                           Lost
  A6TG35                    ATP synthase epsilon chain                                                                                             Lost
  B5XZ37                    ATP-dependent protease ATPase subunit HslU                                                                             Lost
  B5XUB1                    Biosynthetic arginine decarboxylase                                                                                    Lost
  A6TC48                    Cell division protein ZipA                                                                                             Lost
  A6TAX5                    Cell division topological specificity factor                                                                           Lost
  A6T4F4                    Chaperone protein DnaK                                                                                                 Upregulated by 1.73 folds
  B5XT51                    Chromosomal replication initiator protein DnaA                                                                         Lost
  A6TDC6                    Cobalamin biosynthesis protein CobD                                                                                    Upregulated[\*](#t002fn001){ref-type="table-fn"}
  A6TAW4                    D-amino acid dehydrogenase                                                                                             Lost
  A6T739                    Dihydroorotate dehydrogenase (quinone)                                                                                 Lost
  B5XWP9                    Electron transport complex subunit C                                                                                   Lost
  B5XWS2                    Glucans biosynthesis protein D                                                                                         Lost
  A6TGV0                    Glycerol-3-phosphate acyltransferase                                                                                   Lost
  A6TDR6                    Glycine cleavage system H protein                                                                                      Lost
  B5XNC0                    Large-conductance mechanosensitive channel                                                                             Lost
  A6TFK0                    L-lactate dehydrogenase                                                                                                Lost
  A6TEQ3                    Malate dehydrogenase                                                                                                   Lost
  B5XXP0                    NAD(P)H dehydrogenase (quinone)                                                                                        Lost
  A6TBX3                    NADH-quinone oxidoreductase subunit B                                                                                  Lost
  A6TBX2                    NADH-quinone oxidoreductase subunit C/D                                                                                Lost
  A6TC99                    Phosphoribosylaminoimidazole-succinocarboxamide synthase                                                               Upregulated by 2.52 folds
  Q07411                    Polyphosphate kinase                                                                                                   Lost
  O32719                    Probable malate:quinone oxidoreductase (Fragment)                                                                      Upregulated[\*](#t002fn001){ref-type="table-fn"}
  A6TDG4                    Prolipoprotein diacylglyceryl transferase                                                                              Lost
  P27219                    PTS system sucrose-specific EIIBC component                                                                            Lost
  A6TC94                    Succinyl-diaminopimelate desuccinylase                                                                                 Lost
  A6THZ7                    Thymidine phosphorylase                                                                                                Lost
  A6TGL3                    Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE                                                           Lost
  A6T4N3                    UDP-N-acetylglucosamine---N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase   Lost

\*refers to the proteins that were only present in CBO-treated KPC-KP cells.

Oxidative stress {#sec014}
----------------

CBO contains a plethora of different chemical compounds which are dominated by a large group of oxygenated terpenes and terpenoids \[[@pone.0214326.ref010]\]. These compounds are hypothesized to be responsible for CBO's action on the bacterial membrane. From our proteomic data, upregulation of proteins such as autonomous glycyl radical cofactor and catalase peroxidase in the CBO-treated KPC-KP cells suggest the presence of significant oxidative stress. Autonomous glycyl radical cofactor is upregulated by 7.07 fold, and acts as a radical domain which protects pyruvate formate lyase from oxidative stress. Wagner et al. (2001) and Shisler et al. (2014) found that upregulation of glycyl radical cofactor indicates oxidative stress which affects the pyruvate formate lyase that is involved in glucose metabolism \[[@pone.0214326.ref026], [@pone.0214326.ref027]\]. In addition, catalase peroxidase, an enzyme which alleviates oxidative stress from reactive oxygen species (ROS), was also induced when KPC-KP cells were exposed to CBO. Under condition of oxidative stress, high abundance ROS cause oxidative damage to nucleic acids \[[@pone.0214326.ref028]\]. The detection of the DNA mismatch repair protein MutS and the DNA ligase following the exposure to CBO showed that genetic materials of KPC-KP had been damaged, and that elevated expression of these proteins could alleviate some of the oxidative DNA damage. The work of Vogel et al. (2011) showed that oxidative stress leads to the degradation of ribosomal protein \[[@pone.0214326.ref029]\] and this appears to be in line with our findings in CBO-treated KPC-KP cells where 14 ribosomal proteins and ribosome related proteins showed decreased abundance. Specifically, 30S ribosomal protein S3; 50S ribosomal proteins L17, L32, L34 and L5; ribosomal protein L11 methyltransferase; ribosomal RNA large subunit methyltransferase E, F and I; ribosomal RNA small subunit methyltransferase B and G; ribosome maturation factor M and P, and ribosome binding factor A were all reduced in abundance. As one of the key proteins in the maturation of 30S ribosomal subunit, ribosome maturation factor RimP protein is crucial in the process of protein translation by allowing correct pairing of the mRNA and the corresponding anticodon of the tRNA \[[@pone.0214326.ref030], [@pone.0214326.ref031]\]. In agreement with this finding is the decrease in abundance of the other three 50S ribosomal subunit fragments namely, L5, L17 and L32. This further supports the idea that induction of oxidative stress by CBO affects the abundance of ribosomal subunit fragments, as a result of the denaturation of protein fragments or the interruption of protein synthesis in KPC-KP cells. Cosentino et al. (2014) found that bergamot essential oil induced the production of ROS in polymorphonuclear leukocytes, contributing to enhanced eradication of infection \[[@pone.0214326.ref032]\]. Another study by Yoo et al (2005) also suggest that eugenol, one of the main constituents of essential oils such as from nutmeg and cinnamon bark induces the production of ROS in leukemia cells, eventually killing the cells by initiating apoptosis \[[@pone.0214326.ref033]\]. The induction of oxidative stress by essential oils seems to be in conflict with the perception that essential oils contain high concentration of antioxidants. We previously found that the CBO used in this study comprised 13 compounds, of which nine were antioxidants whereas the other four were not \[[@pone.0214326.ref010], [@pone.0214326.ref034]--[@pone.0214326.ref038]\]. These non-antioxidant compounds may be responsible for inducing the oxidative stress observed, by generating ROS or inhibiting anti-oxidizing systems \[[@pone.0214326.ref039]\]. Mimica-Dukić et al. (2016) suggested that essential oils may act both as antioxidants and also as pro-oxidant due to their complex chemistry \[[@pone.0214326.ref040]\]. Additionally, a single compound might exhibit dual antioxidant and prooxidant effects. For instance, Bezerra et al. (2017) found that eugenol had such dual effects, acting as an antioxidant in free-radical scavenging while inducing DNA damage via ROS generation \[[@pone.0214326.ref041]\]. So, the prooxidant activity within CBO may contribute to the oxidative stress, leading to lipid peroxidation in the cell membrane, while inhibiting the antioxidant activity, as indicated in the proteomic profile.

KEGG pathway analysis {#sec015}
---------------------

When analysing significant pathways via the Panther classification system we found that the main pathways associated with the proteins identified included the lipid, cell wall and lipopolysaccharide biosynthesis pathways.

### Lipid biosynthesis {#sec016}

Lipids have critical functions in the bacterial cytoplasmic and outer membranes in separating the bacterial cytoplasm from the external environment \[[@pone.0214326.ref042]\]. KEGG pathway analysis identified 4 proteins which are involved in the lipid biosynthesis pathway that were affected by CBO treatment. Two of these proteins were downregulated in CBO-treated KPC-KP cells: 3-hydroxydecanoyl-\[acyl-carrier-protein\] dehydratase (-3.46 fold) and acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (-1.08 fold). While two other proteins were undetectable following CBO treatment: glycerol-3-phosphate acyltransferase and large-conductance mechanosensitive channel protein. The former two proteins are key components in the fatty acid biosynthesis pathway of Gram-negative bacteria. Acetyl-coenzyme A carboxylase carboxyl transferase is one of the major enzymes in the synthesis of malonyl-CoA, a substrate required in the synthesis of fatty acids \[[@pone.0214326.ref043]\]. 3-hydroxydecanoyl-\[acyl-carrier-protein\] dehydratase functions as an essential mediator in the synthesis of phospholipids in bacteria \[[@pone.0214326.ref044], [@pone.0214326.ref045]\]. As shown in [Table 1](#pone.0214326.t001){ref-type="table"}, glycerol-3-phosphate acyltransferase (G3PAT) was undetectable in the CBO-treated KPC-KP cells. G3PAT, a rate determining enzyme belonging to the glycerolphospholipid metabolism pathway catalyzes the synthesis of phosphatidic acid from glycerol-3-phosphate and long-chain acyl-CoA, is an essential precursor in the synthesis of the bacterial phospholipid bilayer \[[@pone.0214326.ref046], [@pone.0214326.ref047]\]. The absence of G3PAT indicates a perturbed bacterial membrane repair system. This further indicates a disruption in the integrity of the phospholipid membrane in CBO-treated KPC-KP cells. The absence of the large-conductance mechanosensitive channel protein in the treated group also indicated a disrupted membrane structure as this channel regulates membrane stretching and stability under osmotic stress \[[@pone.0214326.ref048], [@pone.0214326.ref049]\]. Upon exposure to CBO, oxidative stress may promote protein denaturation and so affect bacterial cell membrane stretch capacity under osmotic pressure, eventually leading to increased CBO influx and bacterial cell killing.

### Cell wall biosynthesis {#sec017}

Peptidoglycan in the cell wall is a major structural component in prokaryotic cells, forming a stable layer which protects the bacteria from lysis under osmotic stress \[[@pone.0214326.ref050]\]. The proteomic profile showed that three essential proteins in bacterial cell wall synthesis were lost upon exposure to CBO. This may indicate that CBO inhibited the expression of these proteins or that CBO-induced oxidative stress resulted in degradation of these proteins, so preventing cell wall synthesis and repair, and eventually causing cell death. These proteins included UDP-N-acetylglucosamine---N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG); penicillin-binding protein activator LpoB and succinyl-diaminopimelate desuccinylase. The MurG protein is involved in the biosynthesis of the N-acetylmuramic acid-N-acetylglucosamine intermediate, which form a single unit of peptidoglycan cell wall. In the absence of murG, no N-acetylmuramic acid would not be linked to N-acetylglucosamine, preventing the formation of peptidoglycan bilayer linkage and eventually killing the cell due to osmotic pressure and oxidative stress \[[@pone.0214326.ref050]\]. Additionally, succinyl-diaminopimelate desuccinylase also play a major role in maintaining the structure and integrity of the peptidoglycan, as this protein is essential in the synthesis of meso-diaminopimelic acid which is one of the penta-peptides found linked to N-acetylmuramic acid, and is crucial for the cross-linkage with the opposite layer of N-acetylglucosamine. Interestingly, penicillin-binding protein activator LpoB which stimulates the biosynthesis of peptidoglycan molecules was not detected in CBO treated KPC-KP cells. These findings may indicate that the peptidoglycan biosynthesis and repairing had been completely shut down \[[@pone.0214326.ref051]\].

### Lipopolysaccharide biosynthesis {#sec018}

Lipopolysaccharide (LPS) is a highly acylated saccharolipid located on the outer layer of the outer membrane of Gram-negative bacteria. LPS is crucial in the maintenance of membrane integrity and has a barrier function which prevents the passive diffusion of hydrophobic solutes, such as antibiotics and detergents into the cell \[[@pone.0214326.ref052]\]. Many studies have postulated that CBO exerts its bactericidal activity through damage to the outer membrane which allows other bactericidal molecules to enter the cell, eventually killing the cells \[[@pone.0214326.ref011], [@pone.0214326.ref015], [@pone.0214326.ref016]\]. LPS consist of a few components including lipid A; core oligosaccharide and O-antigen \[[@pone.0214326.ref053]\]. We identified three proteins that are involved in LPS biosynthesis that became undetectable upon CBO exposure. These were O-antigen export system ATP-binding protein (RfbB); UDP-4-amino-4-deoxy-L-arabinose---oxoglutarate aminotransferase (arnB) and UDP-3-O-acyl-N-acetylglucosamine deacetylase (lpxC). In order to achieve resistance towards antibiotics such as polymyxin, the 4-amino-4-deoxy-L-arabinose moiety must be added to the lipid A \[[@pone.0214326.ref054]\]. This reaction is catalyzed by the arnB protein which is not detected in the KPC-KP cells exposed to CBO. Furthermore, lpxC protein, a critical enzyme which catalyzes the synthesis of lipid A was also undetectable in CBO-treated KPC-KP cells. 90% of the bacterial outer membrane consists of lipid A, which is crucial for the attachment of core oligosaccharide as well as o-antigen, granting antibiotic resistance to bacteria while maintaining the membrane integrity. In the absence of the lpxC protein, the outer membrane integrity cannot be maintained, compromising cellular resistance against antibiotics. Due to the importance of this protein in lipid A biosynthesis, lpxC has been a target for the development of novel antimicrobial drugs \[[@pone.0214326.ref055], [@pone.0214326.ref056]\]. The O-antigen export system ATP-binding protein, which facilitates the export of O-antigen into the outer membrane was also not detected following exposure to CBO. Thus, CBO may contain compounds that inhibit the expression of these important membrane proteins and sensitize bacteria to antibiotics and changes in osmotic pressure.

qRT-PCR analysis of differentially expressed proteins {#sec019}
-----------------------------------------------------

### Standard curve for qRT-PCR {#sec020}

We selected four genes for further validation of our proteomic data using qRT-PCR together with two housekeeping genes, namely *3-hydroxydecanoyl-\[acyl-carrier-protein\] dehydratase* (*fabA*), *cytidine deaminase* (*cdd*), *thiamine phosphate synthase* (*thiE*), *uridine phosphorylas*e (*udp*), *16s rRNA* and *OmpK36 porin*. Out of these, three were significantly higher in abundance and one was less abundant in the proteomic profile following exposure to CBO. The designed primers for each selected genes were listed in [S1 Table](#pone.0214326.s003){ref-type="supplementary-material"}. Their efficiency ranged within 90 and 100%.

### Relative expression level of selected genes {#sec021}

The relative abundance of mRNA for the differentially expressed proteins investigated was measured by qRT-PCR, comparing the untreated cells with CBO-treated KPC-KP cells ([Fig 3](#pone.0214326.g003){ref-type="fig"}). Proteomic profiling found that *fabA* was downregulated by -3.46 fold, whereas *cdd*, *thiC* and *udp* were upregulated by 1.62, 2.08 and 2.57 fold respectively ([Table 1](#pone.0214326.t001){ref-type="table"}). The qRT-PCR analysis of mRNA abundance found that *fabA* was downregulated by 0.8 fold whereas *cdd*, *thiC* and *udp* were upregulated by 0.8, 11 and 1.4 fold respectively. The pattern in mRNA abundance change following CBO treatment mirrors that of the protein abundance for these four gene products, indicating that at least part of the change in the abundance for these four proteins is due to changes in gene transcription. The differences in the magnitude of the fold changes between the protein abundance and mRNA transcript abundance may be a consequence of oxidative stress-induced protein degradation or different stabilities for the mRNA species. Nevertheless, the trends in expression changes shown in the protein profiles and mRNA transcription levels are consistent with each other and validate our results obtained from proteomic profiling.

![Expression patterns of *fabA*, *cdd*, *thiE* and *udp* genes in KPC-KP cells subjected to CBO treatment.\
Results are presented as differential relative transcript abundance.](pone.0214326.g003){#pone.0214326.g003}

CBO exerts antimicrobial activity on KPC-KP cells through membrane disruption, and proteomic profiling shows that the membrane damage induced was due to oxidative stress. This is supported by the increased in abundance of oxidative stress regulators when KPC-KP cells were exposed to CBO. A review by Itri et al. (2014) consolidated information from studies involving oxidative stress and membrane damage. The study concluded that oxidative stress would reduce the permeability and integrity of the plasma membrane, leading to leakage of intracellular contents and eventually killing the bacterial cells \[[@pone.0214326.ref057]\]. The membrane disruptive effects of CBO could also be deduced from our proteomic profiles, and numerous proteins showed decreased abundance or were lost following CBO exposure. Interestingly, CBO treatment also interfered with the biosynthesis of the plasma membrane, cell wall and outer membrane, disabling the structural repair system. The proteomic profiles were validated using qRT-PCR analysis, where proteomic changes were mirrored by changes in corresponding mRNA abundance. Together with the evidence from our previous study on the antimicrobial potential and the mode of action of CBO against KPC-KP cells \[[@pone.0214326.ref011]\], we showed that the antibacterial activity of CBO derives from its ability to induce oxidative stress in bacterial cells. The resulting oxidation disrupts the bacterial membrane, eventually enabling the influx of ROS into the cells and, at the same time, leads to intracellular content leakage. ROS induce genetic damage and impair DNA and membrane repair systems. Our results demonstrate that CBO causes oxidative stress, damage to bacterial membranes, cellular leakage and cell killing.
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